noninvasive vivo quantitation boron necessary obtaining pharmacokinetic data candidate boronated delivery agents developed boron neutron capture therapy bnct data turn facilitate optimization temporal sequence boronated drug infusion neutron irradiation current approaches obtaining pharmacokinetic data include positron emission tomography employing labeled boronated delivery agents ex vivo neutron activation analysis blood occasionally tissue samples nuclear magnetic resonance nmr techniques general nmr approaches hindered poor signal noise achieved large quadrupole moments case low gyromagnetic ratio combined low physiological concentrations isotopes clinical conditions preliminary study examines feasibility proton nmr spectroscopy applications utilized proton nmr spectroscopy investigate detectability fructose typical physiological concentrations encountered bnct boron delivery agents currently undergoing clinical trials japan europe study includes 1h spectroscopic characterization identify useful spectral features purposes detection quantification study examines potential interferences demonstrates linear nmr signal response concentration presents bpa nmr spectra ex vivo blood samples vivo brain tissues f NUMBER p boronophenylalanine b NUMBER b NUMBER b NUMBER p boronophenylalanine bpa f bpa f phase high resolution bpa f ii